ENTITY
Chongqing Zhifei Biological Products

Chongqing Zhifei Biological Products (300122 CH)

94
Analysis
Health CareChina
Chongqing Zhifei Biological Products Company Ltd. researches, manufactures, and sells vaccines and biological products including prevention products, blood products, diagnostic reagents, and therapeutic agents.
more
15 Jul 2021 09:36

Beijing Wantai Biological (603392.CH) - How to Support Its High Valuation?

This article mainly analyzed Wantai in terms of the two core business IVD and HPV vaccine, their business outlook, the market pattern and the...

Logo
225 Views
Share
30 May 2021 09:10

China Healthcare Weekly (May.28)

This article mainly analyzed the two new alliance volume-based purchase documents, COVID-19 vaccine development, CDE acceptance of biological...

Logo
198 Views
Share
12 May 2021 09:16

Pre-IPO Clover Biopharmaceuticals - Insights on the Core Technology and Product Candidates

The article analyzed Clover's core technology platform, COVID-19 vaccine and SCB-808 in pipeline,future challenge on competition and potential...

Logo
390 Views
Share
09 May 2021 09:16

China Healthcare Weekly (May.7)

The article analyzed the potential impact on Biden’s proposal to waive IP protection on COVID-19 shots,market size of COVID-19 vaccine,new...

Logo
236 Views
Share
26 Apr 2021 09:05

Chongqing Zhifei Biological Products (300122.CH) - Could Zhifei Support Its Valuation?

After its COVID-19 vaccine got approved in March, the investment logic is different. This article analyzed the key catalysts of Zhifei (agency...

Logo
220 Views
Share
x